Novartis is offering a $250,000 prize to fund development of pioneering innovation with great potential in advancing Assistive Tech for Multiple Sclerosis. Applications will be accepted until January 10, 2020, and the winners will be announced during a panel discussion among experts in the field at SXSW in Austin, TX.